Monday, September 25, 2017

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Experiences Lighter ...

www.fidaily.com/imprimis-pharmaceuticals-inc-nasdaqimmy...lighter.../523939
4 hours ago - The Company operates through the business of developing drug therapies ... on developing and dispensing a portfolio of non-proprietary compounded drugs for 
Post a Comment